Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Phys Written Answersendocrine

Phys Written Answers · endocrine

Pituitary Disease — Written Clinical Reasoning

DCE long-case preparation: structured written reasoning for pituitary disease management, including acromegaly workup and treatment, pituitary apoplexy emergency management, and hypopituitarism hormone replacement.

7 min readVerification in progress

Target exams

FRACP DCEMRCP Part 2ABIM Internal Medicine
On this page
Study tools

Target exams

FRACP DCEMRCP Part 2ABIM Internal Medicine
Prompt
DCE long-case preparation: structured written reasoning for pituitary disease management, including acromegaly workup and treatment, pituitary apoplexy emergency management, and hypopituitarism hormone replacement.

SAQ 1 — Pituitary Apoplexy Emergency Management (25 marks, 30 minutes)

Prompt: Outline your immediate and integrated management of this patient, including the emergency treatment, problem list, investigation interpretation, the decision on surgical versus conservative management, hormone replacement regimen with doses, and the long-term follow-up plan. Justify each decision with reference to evidence and guidelines. [1]

Model Answer

Immediate emergency management (5 marks): [1]

This patient has pituitary apoplexy — acute haemorrhage into a pituitary macroadenoma — presenting as a neuroendocrine emergency. He has two immediately life-threatening problems: presumptive adrenal crisis (ACTH deficiency causing hypotension and hyponatraemia) and progressive visual loss from chiasm and cavernous sinus compression. [1]

  1. Empirical intravenous hydrocortisone immediately. Per the UK guidelines for pituitary apoplexy (Rajasekaran 2011, PMID 21044119), empirical steroid therapy is indicated for patients with haemodynamic instability, altered consciousness, reduced visual acuity, or severe visual field defects. This patient meets all four criteria. Give hydrocortisone 100 to 200 mg intravenous bolus, followed by either 50 to 100 mg intramuscularly every 6 hours or 2 to 4 mg per hour continuous intravenous infusion. This treats the presumptive adrenal crisis (cortisol of 95 nmol/L confirms ACTH deficiency) and reduces peritumoural oedema. Do NOT wait for cortisol results before treating. [1]

  2. Fluid resuscitation — intravenous normal saline to correct hypotension and hyponatraemia. Monitor input and output, central venous pressure if unstable. [1]

  3. Close neurological monitoring — GCS hourly, visual acuity and fields serially (at least daily), cranial nerve examination. Notify the neurosurgical and endocrine teams immediately. [1]

  4. Airway and breathing — the drowsy patient may deteriorate; have a low threshold for ICU admission. [1]

Problem list (4 marks): [1]

  1. Pituitary apoplexy — acute haemorrhage into a pituitary macroadenoma (medical and potentially surgical emergency)
  2. Secondary adrenal insufficiency (ACTH deficiency) — cortisol 95 nmol/L, hypotension, hyponatraemia
  3. Central hypothyroidism — free T4 8 pmol/L with inappropriately normal TSH
  4. Right third cranial nerve palsy and bitemporal hemianopia — cavernous sinus and chiasm compression
  5. Hyponatraemia (sodium 128 mmol/L) — from cortisol deficiency and possibly SIADH from the acute event
  6. Warfarin therapy — relative contributor to the haemorrhage; reverse with vitamin K and prothrombinex in consultation with haematology
  7. Atrial fibrillation and hypertension — comorbidities requiring ongoing management
  8. Likely non-functioning macroadenoma (prolactin 220 mU/L is a stalk effect, not a prolactinoma) [1]

Investigation interpretation (4 marks): [1]

  • Cortisol 95 nmol/L: Diagnostic of ACTH deficiency in the acute setting. A 9 AM cortisol below 100 nmol/L in a patient with pituitary disease does not require dynamic confirmation. This explains the hypotension, drowsiness, and hyponatraemia.
  • Free T4 8 pmol/L with TSH 0.8 mU/L: Central hypothyroidism — the free T4 is low with an inappropriately normal TSH (in primary hypothyroidism the TSH would be elevated). This confirms hypothalamic-pituitary axis dysfunction.
  • Prolactin 220 mU/L: This is only mildly elevated and is disproportionate to the 2.5 cm tumour — it is the STALK EFFECT (compression of the pituitary stalk removing tonic dopamine inhibition), not a macroprolactinoma. A true macroprolactinoma of this size would have a prolactin above 5000 mU/L. This is a non-functioning adenoma — the treatment is surgery if needed, not cabergoline.
  • Sodium 128 mmol/L: Due to cortisol deficiency (cortisol is needed for free water clearance; deficiency causes increased ADH secretion). May also have a component of SIADH from the acute neurological event. Will correct with hydrocortisone replacement.
  • CT and MRI: Confirm a pituitary macroadenoma with acute haemorrhage and infarction — the classic radiological appearance of apoplexy. [1]

Surgical versus conservative management decision (4 marks): [1]

Per the UK guidelines, the decision is made in a pituitary multidisciplinary team (endocrinology, neurosurgery, ophthalmology). The indications for surgical decompression (transsphenoidal) within 1 to 2 weeks are:

  • Severely reduced visual acuity
  • Severe and persistent visual field defects
  • Deteriorating level of consciousness
  • Worsening neurological symptoms [1]

This patient has a right CN III palsy, a bitemporal hemianopia, and is drowsy — he meets criteria for surgical consideration. The decision would be: urgent neurosurgical referral for transsphenoidal decompression, performed after medical stabilisation with hydrocortisone and fluids. If his visual acuity or consciousness deteriorates, surgery would be expedited. [1]

Conservative management (hydrocortisone, fluids, and observation without surgery) is appropriate for patients with no visual compromise or with improving symptoms. The evidence suggests that both approaches can yield good outcomes, but surgery offers faster visual recovery for patients with significant visual deficit. [1]

Hormone replacement regimen (4 marks): [1]

  1. Hydrocortisone FIRST — 100 mg IV stat, then 50 mg IV every 6 hours or continuous infusion. Once stable, convert to oral hydrocortisone 10 mg morning, 5 mg noon, 5 mg at 4 PM (total 20 mg daily). Provide patient education, MedicAlert bracelet, and emergency hydrocortisone injection kit with sick day rules. [1]

  2. Levothyroxine AFTER cortisol is established — start levothyroxine 1.6 microgram per kg per day (approximately 100 to 125 microgram daily) once hydrocortisone is commenced. NEVER start levothyroxine before hydrocortisone — the increased T4 accelerates cortisol clearance and precipitates adrenal crisis. Monitor free T4 (NOT TSH — TSH is unreliable in central hypothyroidism) and titrate to mid-normal free T4. [1]

  3. Sex hormone replacement — once stable, assess gonadal axis. This man would need testosterone replacement if LH/FSH and testosterone are low. [1]

  4. GH — assess for GH deficiency once stable; may benefit from somatropin replacement if confirmed deficient and no contraindications. [1]

  5. Desmopressin — monitor for diabetes insipidus (especially after surgery). If polyuria develops, start desmopressin 100 to 200 microgram orally two to three times daily. [1]

Long-term follow-up (4 marks): [1]

  • Lifelong endocrine follow-up — most patients develop permanent hypopituitarism after apoplexy and require ongoing multi-axis replacement.
  • Visual fields and acuity — formal perimetry at 3 months, then annually, or sooner if symptomatic.
  • MRI surveillance — at 3 months post-event, then annually for the first 3 years to monitor for residual or recurrent tumour.
  • Pituitary panel — monitor cortisol (hydrocortisone adequacy), free T4, testosterone, IGF-1 at each visit. Adjust replacement as needed.
  • Patient education — steroid card, MedicAlert, sick day rules, emergency hydrocortisone kit. Ensure family and GP know the sick day rules.
  • Address cardiovascular risk — this patient has hypertension and atrial fibrillation; manage anticoagulation carefully (the apoplexy was potentially precipitated by warfarin). [1]

Physician Medicine Pro

Continue reading

You have read the opening of this written answer. The complete unit — every section and its primary-source references — is part of the Physician Medicine fellowship library.

Sign in to continueSee pricing
References5ShowHide
  1. [1]Katznelson L, Laws ER, Melmed S, et al. Acromegaly: an endocrine society clinical practice guideline J Clin Endocrinol Metab, 2014.PMID 25356808
  2. [2]Rajasekaran S, Vanderpump M, Baldeweg S, et al. UK guidelines for the management of pituitary apoplexy Clin Endocrinol (Oxf), 2011.PMID 21044119
  3. [3]Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab, 2011.PMID 21296991
  4. [4]Trainer PJ, Drake WM, Katznelson L, et al. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant N Engl J Med, 2000.PMID 10770982
  5. [5]Tomlinson JW, Holden N, Hills RK, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group Lancet, 2001.PMID 11273062
Physician Medicine Pro

$29/ monthor $279 / year

The complete Physician Medicine library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousMultiple Endocrine Neoplasia — Written Clinical ReasoningendocrineNextReproductive Endocrinology — Written Clinical Reasoningendocrine